{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T18:38:19Z","timestamp":1774723099210,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["2022-CP-IDMH-018"],"award-info":[{"award-number":["2022-CP-IDMH-018"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["2022-CP-IDMH-018"],"award-info":[{"award-number":["2022-CP-IDMH-018"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000950","name":"Cancer Council South Australia","doi-asserted-by":"publisher","award":["Beat Cancer Fellowship"],"award-info":[{"award-number":["Beat Cancer Fellowship"]}],"id":[{"id":"10.13039\/501100000950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000950","name":"Cancer Council South Australia","doi-asserted-by":"publisher","award":["Beat Cancer Fellowship"],"award-info":[{"award-number":["Beat Cancer Fellowship"]}],"id":[{"id":"10.13039\/501100000950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Although sexual dysfunction is a common treatment side-effect affecting men\u2019s quality of life, many prostate cancer patients do not receive or seek out treatments for erectile dysfunction (ED). The aims of this study are to investigate the extent and patterns of use of ED treatments and their perceived impact at different times following prostate cancer treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective cohort study included all men on the South Australian prostate cancer registry who completed one or more Patient Reported Outcome Measures (PROMs) survey from 2016 to 2023 (<jats:italic>n<\/jats:italic>\u2009=\u20095561). Outcomes included self-reported use of ED treatment (oral medications, intra-cavernosal injections (ICI) and vacuum pumps) and their impact men\u2019s sex life at various time points after treatment. The type and timing of ED treatments used was analysed descriptively. Sociodemographic and clinical characteristics associated with utilisation and self-reported satisfaction were examined using multivariable mixed-effects binomial logistic regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Post-treatment use of ED treatments did not exceed 43% at any timepoint, with utilisation rates decreasing over time. Oral medications were most frequently used, while vacuum pump and ICI use was limited. Oral medications were more likely to be used at three-months (odds ratio [OR]\u2009=\u20092.48; 95% confidence interval [95%CI]\u2009=\u20091.88\u20133.27) and six-months (OR\u2009=\u20092.10; 95%CI\u2009=\u20091.63\u20132.27) than at 12-months post-treatment, and among men from higher socioeconomic areas (OR\u2009=\u20092.41; 95%CI\u2009=\u20091.47\u20133.93, highest vs. lowest quintile), and following prostatectomy (OR\u2009=\u20094.37; 95%CI\u2009=\u20092.92\u20136.42), and less likely among older men (OR\u2009=\u20090.08; 95%CI\u2009=\u20090.05\u20130.13, &lt;\u200960yrs vs. 70-79yrs). Men were more likely to report an improved sex life with oral medication use at two-years (OR\u2009=\u20093.79; 95%CI\u2009=\u20091.69\u20138.47) and five-years (OR\u2009=\u20093.07; 95%CI\u2009=\u20091.51\u20136.25) post-treatment compared with 12-months or if they were socioeconomically advantaged (OR\u2009=\u20093.22; 95%CI\u2009=\u20091.30\u20137.96, highest vs. lowest quintile).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>A substantial proportion of Australian men do not access or continue to use ED treatments after prostate cancer treatment, with many users reporting only modest effects on their sex life. There is a need to improve access to and maintenance of ED treatments following prostate cancer treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12894-025-01702-0","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:43:59Z","timestamp":1738320239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of erectile dysfunction treatments after prostate cancer treatment and their perceived impact on men\u2019s sex life: an analysis of patient reported outcome survey data"],"prefix":"10.1186","volume":"25","author":[{"given":"Megan","family":"Charlick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tenaw","family":"Tiruye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Ettridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Jay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerri","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"1702_CR1","unstructured":"Australian Institute of Health and Welfare. Cancer in Australia 2021. In. Canberra: AIHW; 2021."},{"issue":"nov27 2","key":"1702_CR2","doi-asserted-by":"publisher","first-page":"b4817","DOI":"10.1136\/bmj.b4817","volume":"339","author":"DP Smith","year":"2009","unstructured":"Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, Ward J, O\u2019Connell DL, Armstrong BK. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009;339(nov27 2):b4817\u20134817.","journal-title":"BMJ"},{"key":"1702_CR3","doi-asserted-by":"crossref","unstructured":"Mazariego CG, Egger S, King MT, Juraskova I, Woo H, Berry M, Armstrong BK, Smith DP. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study. BMJ 2020:m3503.","DOI":"10.1136\/bmj.m3503"},{"issue":"1","key":"1702_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.21037\/tau.2016.08.12","volume":"6","author":"SK Chambers","year":"2017","unstructured":"Chambers SK, Chung E, Wittert G, Hyde MK. Erectile dysfunction, masculinity, and psychosocial outcomes: a review of the experiences of men after prostate cancer treatment. Translational Androl Urol. 2017;6(1):60\u20138.","journal-title":"Translational Androl Urol"},{"issue":"2","key":"1702_CR5","doi-asserted-by":"publisher","first-page":"e12497","DOI":"10.1111\/ecc.12497","volume":"26","author":"MK Hyde","year":"2017","unstructured":"Hyde MK, Newton RU, Galv\u00e3o DA, Gardiner RA, Occhipinti S, Lowe A, Wittert GA, Chambers SK. Men\u2019s help-seeking in the first year after diagnosis of localised prostate cancer. Eur J Cancer Care. 2017;26(2):e12497.","journal-title":"Eur J Cancer Care"},{"issue":"11","key":"1702_CR6","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1007\/s00520-020-05389-x","volume":"28","author":"CG Mazariego","year":"2020","unstructured":"Mazariego CG, Juraskova I, Campbell R, Smith DP. Long-term unmet supportive care needs of prostate cancer survivors: 15-year follow-up from the NSW prostate Cancer Care and outcomes Study. Support Care Cancer. 2020;28(11):5511\u201320.","journal-title":"Support Care Cancer"},{"key":"1702_CR7","unstructured":"Ong W, Krishnapradasad K, Bensley J, Steeper M, Beckmann K, Breen S, King M, Mark S, O\u2019Callaghan M, Patel M et al. Prostate Cancer Across Australia and New Zealand PCOR-ANZ 2015\u20132021 Annual Report 2023. In.; 2024."},{"key":"1702_CR8","unstructured":"EAU guidelines on Sexual and Reproductive Health: 5. Management of Erectile Dysfunction [https:\/\/uroweb.org\/guidelines\/sexual-and-reproductive-health\/chapter\/management-of-erectile-dysfunction.]."},{"key":"1702_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","volume":"200","author":"A Burnett","year":"2018","unstructured":"Burnett A, Nehra A, Breau R, Culkin D, Faraday M, Hakin L, Heidelbaugh J, Khera M, McVary K, Miner M, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633.","journal-title":"J Urol"},{"issue":"10","key":"1702_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5694\/mja13.11028","volume":"200","author":"E Chung","year":"2014","unstructured":"Chung E, Gillman M. Prostate cancer survivorship: a review of erectile dysfunction and penile rehabilitation after prostate cancer therapy. Med J Aust. 2014;200(10):582\u20135.","journal-title":"Med J Aust"},{"issue":"2","key":"1702_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1097\/01.ju.0000165342.85300.14","volume":"174","author":"RA Stephenson","year":"2005","unstructured":"Stephenson RA, Mori M, Hsieh YC, Beer TM, Stanford JL, Gilliland FD, Hoffman RM, Potosky AL. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and end results prostate Cancer outcomes Study. J Urol. 2005;174(2):646\u201350. discussion 650.","journal-title":"J Urol"},{"issue":"2","key":"1702_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ijrobp.2018.01.055","volume":"101","author":"RT Dess","year":"2018","unstructured":"Dess RT, Devasia TP, Aghdam N, Jackson WC, Soni PD, Smith CP, Mitchell AL, Suy S, Hamstra DA, Jolly S, et al. Patient-reported sexual aid utilization and efficacy after Radiation Therapy for localized prostate Cancer. Int J Radiation Oncology*Biology*Physics. 2018;101(2):376\u201386.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"10","key":"1702_CR13","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.jsxm.2021.07.012","volume":"18","author":"LM Walker","year":"2021","unstructured":"Walker LM, Sears CS, Santos-Iglesias P. Hard times: prostate Cancer patients\u2019 experiences with Erectile Aids. J Sex Med. 2021;18(10):1775\u201387.","journal-title":"J Sex Med"},{"issue":"7","key":"1702_CR14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1080\/00224499.2018.1476444","volume":"56","author":"JM Ussher","year":"2019","unstructured":"Ussher JM, Perz J, Rose D, Kellett A, Dowsett G. Sexual Rehabilitation after prostate Cancer through assistive aids: a comparison of Gay\/Bisexual and Heterosexual men. J Sex Res. 2019;56(7):854\u201369.","journal-title":"J Sex Res"},{"key":"1702_CR15","unstructured":"South Australian Prostate Cancer Clinical Outcomes Collaborative. (SA-PCCOC) [https:\/\/www.prostatehealth.org.au\/]."},{"issue":"6","key":"1702_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","volume":"56","author":"JT Wei","year":"2000","unstructured":"Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899\u2013905.","journal-title":"Urology"},{"key":"1702_CR17","doi-asserted-by":"crossref","unstructured":"Schover L, Fouladi R, Warneke M, Neese L, Zippe C, Kiupelian P. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer. 2002;95(11):2397\u2013407.","DOI":"10.1002\/cncr.10970"},{"key":"1702_CR18","unstructured":"Remoteness Areas. https:\/\/www.abs.gov.au\/statistics\/standards\/australian-statistical-geography-standard-asgs-edition-3\/jul2021-jun2026\/remoteness-structure\/remoteness-areas"},{"key":"1702_CR19","unstructured":"Socio-Economic Indexes for Australia (SEIFA). 2016: Index of Relative Socio-economic Advantage and Disadvantage, 2016. https:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/Lookup\/2033.0.55.001Main+Features12016."},{"key":"1702_CR20","unstructured":"EPIC-26 The expanded Prostate Cancer Index Composite Short Form. https:\/\/medicine.umich.edu\/sites\/default\/files\/content\/downloads\/EPIC-SF-6.2002_0.pdf."},{"key":"1702_CR21","unstructured":"StataCorp. Stata Statistical Software. In. College Station, TX; 2023."},{"issue":"6","key":"1702_CR22","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.urology.2006.08.1092","volume":"68","author":"Z Symon","year":"2006","unstructured":"Symon Z, Daignault S, Symon R, Dunn RL, Sanda MG, Sandler HM. Measuring patients\u2019 expectations regarding health-related quality-of-life outcomes associated with prostate cancer surgery or radiotherapy. Urology. 2006;68(6):1224\u20139.","journal-title":"Urology"},{"issue":"2","key":"1702_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.juro.2011.03.118","volume":"186","author":"D Wittmann","year":"2011","unstructured":"Wittmann D, He C, Coelho M, Hollenbeck B, Montie JE, Wood DP. Patient preoperative expectations of urinary, bowel, hormonal and sexual functioning do not Match actual outcomes 1 year after radical prostatectomy. J Urol. 2011;186(2):494\u20139.","journal-title":"J Urol"},{"issue":"2","key":"1702_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/0092623X.2013.842194","volume":"41","author":"D Wittmann","year":"2015","unstructured":"Wittmann D, Northouse L, Crossley H, Miller D, Dunn R, Nidetz J, Montie J, Moyad M, Lavin K, Montie JE. A pilot study of potential pre-operative barriers to couples\u2019 sexual recovery after radical prostatectomy for prostate Cancer. J Sex Marital Ther. 2015;41(2):155\u201368.","journal-title":"J Sex Marital Ther"},{"issue":"8","key":"1702_CR25","doi-asserted-by":"publisher","first-page":"e9303","DOI":"10.1002\/pon.9303","volume":"33","author":"M Charlick","year":"2024","unstructured":"Charlick M, Tiruye T, Ettridge K, O\u2019Callaghan M, Sara S, Jay A, Beckmann K. Prostate cancer-related sexual dysfunction and barriers to help seeking: a scoping review. Psycho Oncol. 2024;33(8):e9303.","journal-title":"Psycho Oncol"},{"issue":"10","key":"1702_CR26","doi-asserted-by":"publisher","first-page":"e030856","DOI":"10.1136\/bmjopen-2019-030856","volume":"9","author":"A Dyer","year":"2019","unstructured":"Dyer A, Kirby M, White ID, Cooper AM. Management of erectile dysfunction after prostate cancer treatment: cross-sectional surveys of the perceptions and experiences of patients and healthcare professionals in the UK. BMJ open. 2019;9(10):e030856.","journal-title":"BMJ open"},{"issue":"3","key":"1702_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jsxm.2020.12.017","volume":"18","author":"E Watson","year":"2021","unstructured":"Watson E, Wilding S, Matheson L, Brett J, McCaughan E, Downing A, Wright P, Cross W, Selby P, Butcher H, et al. Experiences of support for sexual dysfunction in men with prostate Cancer: findings from a U.K.-Wide mixed methods study. J Sex Med. 2021;18(3):515\u201325.","journal-title":"J Sex Med"},{"issue":"24","key":"1702_CR28","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1001\/jama.283.24.3217","volume":"283","author":"JFJ Fowler","year":"2000","unstructured":"Fowler JFJ. Comparison of recommendations by urologists and Radiation oncologists for treatment of clinically localized prostate Cancer. JAMA. 2000;283(24):3217.","journal-title":"JAMA"},{"issue":"18","key":"1702_CR29","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/jnci\/djh259","volume":"96","author":"AL Potosky","year":"2004","unstructured":"Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004;96(18):1358\u201367.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1702_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1464-410X.2009.08775.x","volume":"105","author":"JP Mulhall","year":"2010","unstructured":"Mulhall JP, Parker M, Waters BW, Flanigan R. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. BJU Int. 2010;105(1):37\u201341.","journal-title":"BJU Int"},{"key":"1702_CR31","first-page":"167","volume":"10","author":"F Zheng","year":"2023","unstructured":"Zheng F, Yang Z, Li X, Wang A. Factors influencing the quality of sexual life in the older adults: a scoping review. Int J Nurs Sci. 2023;10:167\u201373.","journal-title":"Int J Nurs Sci"},{"key":"1702_CR32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41391-023-00701-2","volume":"27","author":"J Visscher","year":"2024","unstructured":"Visscher J, Hiwase M, Bonevski B, O\u2019Callaghan M. The association of smoking with urinary and sexual function recovery following radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2024;27:222\u20139.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"1702_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.juro.2012.08.089","volume":"189","author":"V Prabhu","year":"2013","unstructured":"Prabhu V, Alukal JP, Laze J, Makarov DV, Lepor H. Long-term satisfaction and predictors of Use of Intracorporeal injections for Post-prostatectomy Erectile Dysfunction. J Urol. 2013;189(1):238\u201342.","journal-title":"J Urol"},{"issue":"9","key":"1702_CR34","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jsxm.2019.05.013","volume":"16","author":"CJ Nelson","year":"2019","unstructured":"Nelson CJ, Saracino RM, Napolitano S, Pessin H, Narus JB, Mulhall JP. Acceptance and Commitment Therapy to increase adherence to Penile Injection Therapy-based Rehabilitation after Radical Prostatectomy: pilot randomized controlled trial. J Sex Med. 2019;16(9):1398\u2013408.","journal-title":"J Sex Med"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01702-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:44:07Z","timestamp":1738320247000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01702-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1702"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01702-0","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Deidentified data were accessed through the SA-PCCOC registry. The registry has ethical approval from the Southern Adelaide Clinical Human Research Ethics Committee (protocol 307.14) to collect patient reported outcome data. SA-PCCOC only enrols patients who have consented to participate in patient reported outcomes surveys and have their clinical data collected prospectively. A waiver of consent has been granted by Southern Adelaide Clinical Human Research Ethics Committee to use participants deidentified data for research purposes (protocol 307.14).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. Ethics approval was given for a waiver of consent for analysis of deidentified data and subsequent publication for findings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}